Apollo Medical Amends Bylaws, Requires 2/3 Vote for Director Removal
Ticker: ASTH · Form: 8-K · Filed: Jan 26, 2024 · CIK: 1083446
| Field | Detail |
|---|---|
| Company | Apollo Medical Holdings, INC. (ASTH) |
| Form Type | 8-K |
| Filed Date | Jan 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: corporate-governance, bylaw-amendment, shareholder-rights
TL;DR
**Apollo Medical just made it way tougher for shareholders to kick out directors, requiring a 2/3 vote now.**
AI Summary
Apollo Medical Holdings, Inc. filed an 8-K on January 26, 2024, reporting that on January 25, 2024, its Board of Directors approved an amendment to the company's bylaws. This amendment changed the required vote for stockholders to remove directors from a simple majority to a two-thirds majority. This change makes it significantly harder for shareholders to remove directors, potentially entrenching the current board and reducing shareholder influence over governance.
Why It Matters
This change reduces shareholder power by making it much harder to remove directors, potentially leading to less accountability from the board to its investors.
Risk Assessment
Risk Level: medium — The increased threshold for director removal could reduce board accountability and shareholder influence, which is a moderate governance risk.
Analyst Insight
A smart investor would review their position, considering that this governance change could reduce shareholder power and potentially impact long-term accountability and stock performance.
Key Players & Entities
- Apollo Medical Holdings, Inc. (company) — the registrant that filed the 8-K
- Board of Directors (company) — approved the bylaw amendment
- January 25, 2024 (date) — date of the earliest event reported
- two-thirds majority (other) — new voting requirement for director removal
- simple majority (other) — previous voting requirement for director removal
Forward-Looking Statements
- Shareholder proposals for board changes will face higher hurdles. (Apollo Medical Holdings, Inc.) — high confidence, target: 2024-12-31
- The board's independence from shareholder pressure may increase. (Apollo Medical Holdings, Inc.) — medium confidence, target: 2024-12-31
FAQ
What was the specific change made to Apollo Medical Holdings, Inc.'s bylaws?
The bylaws were amended to change the required vote for stockholders to remove directors from a simple majority to a two-thirds majority.
When did the Board of Directors approve this bylaw amendment?
The Board of Directors approved the amendment to the bylaws on January 25, 2024.
What is the significance of changing the director removal threshold from a simple majority to a two-thirds majority?
This change makes it significantly more difficult for shareholders to remove directors, potentially entrenching the current board and reducing shareholder influence over corporate governance.
Which section of the Securities Exchange Act of 1934 is this current report filed under?
This current report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the trading symbol and exchange for Apollo Medical Holdings, Inc.'s Common Stock?
The trading symbol for Apollo Medical Holdings, Inc.'s Common Stock is AMEH, and it is registered on The Nasdaq Stock Market LLC.
Filing Stats: 651 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-01-26 07:30:23
Filing Documents
- tm244161d1_8k.htm (8-K) — 27KB
- tm244161d1_ex3-1.htm (EX-3.1) — 6KB
- 0001104659-24-006988.txt ( ) — 205KB
- ameh-20240125.xsd (EX-101.SCH) — 3KB
- ameh-20240125_lab.xml (EX-101.LAB) — 33KB
- ameh-20240125_pre.xml (EX-101.PRE) — 22KB
- tm244161d1_8k_htm.xml (XML) — 3KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 24, 2024, Apollo Medical Holdings, Inc. (the "Company") announced a proposed name change. On January 25, 2024, the Company filed a Certificate of Amendment to the Company's Restated Certificate of Incorporation (the "Amendment") with the Secretary of State of the State of Delaware to change its corporate name from "Apollo Medical Holdings, Inc." to "Astrana Health, Inc.", effective as of 12:01 a.m. Eastern Time on February 26, 2024 (the "Name Change"). Pursuant to Delaware law, a stockholder vote was not necessary to effectuate the Name Change, and the Name Change does not affect the rights of the Company's stockholders. The foregoing summary of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Other Events
Item 8.01 Other Events. In connection with the Name Change, the Company expects that its common stock, which trades on The Nasdaq Stock Market LLC, will cease trading under the ticker symbol "AMEH" and will commence trading on February 26, 2024 under the new ticker symbol "ASTH." There will be no change to the CUSIP number for the Company's common stock. Outstanding stock certificates for shares of the Company's common stock will not be affected by the Name Change and will continue to be valid and need not be exchanged.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment of Restated Certificate of Incorporation of Apollo Medical Holdings, Inc. (effective February 26, 2024). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APOLLO MEDICAL HOLDINGS, INC. Date: January 26, 2024 By: /s/ Brandon Sim Name: Title: Brandon Sim Chief Executive Officer and President